NRTIs in Development

Nucleoside Analog Reverse Transcriptase Inhibitors in Development (April 4, 2011)
To read PDF, click here.
From AIDS InfoNet
Avexa Reaches Agreement With U.S. Regulator (March 31, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Development of New NRTI Festinavir Continues (February 2011)
To read PDF, click here.
In Project Inform Perspective, from Project Inform
New NRTI Festinavir Exhibits Good Anti-HIV Activity and Safety in Phase 1b/2a Study (September 14, 2010)
From HIVandHepatitis.com
Apricitabine Development Should Not Be Halted, Say HIV/AIDS Advocates in Open Letter (June 21, 2010)
From AIDS Treatment Activists Coalition
Avexa Closes Apricitabine Program (May 10, 2010)
Announces CEO resignation, headcount reduction and plan to explore strategic alternatives.
From Avexa Limited
New Kind of Antiretroviral, KP-1461, Clinical Trial Recruiting; Interview With Stephen Becker, M.D. (October 11, 2007)
In AIDS Treatment News, from AIDS Treatment News
Development of DFC, an Investigational NRTI, Is Discontinued (April 4, 2006)
From The Body
New Drugs From Old Classes (Spring 2006)
A listing of NNRTIs, NRTIs and protease inhibitors currently in development.
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America
NRTIs in Development (March 30, 2006)
An overview from Edwin DeJesus, M.D.
From The Body
D-D4FC (RVT, Reverset) Is Active Against NRTI-Resistant Virus in Phase 2B Trial (July 27, 2005)
[Archived Article]
In The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment
Nucleoside Reverse Transcriptase Inhibitors (June 1, 2002)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
DPC 817: Novel Nucleoside Analog Active Against Drug-Resistant Strains (May 31, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Experimental NRTI Drugs (Spring 2001)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation

More Most Viewed Articles

HIV Tools You Can Use

Track Your CD4 Count, Viral Load and More: Use TheBody.com's Health Tracker

TheBody.com's Facebook, Widgets, RSS Feeds and Twitter
Are You at Risk for HIV? Take Our Quiz!
U.S. AS0 Finder U.S. ASO Listings
International ASOs
Find a Therapist or
Psychologist in Your Area

The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.